Innovations Composition for treating lung fibrosis & emphysema & therapeutic method using the same
■Technology Introduction
A therapeutic approach for chronic lung diseases such as COPD and fibrosis, via in vivo reprogramming of endogenous alveolar epithelial cells.
 
■Scientific Innovation
Instead of transplanting in vitro propagated stem cells to injury site, this technology induces vivo reprogramming of endogenous lung cells for therapy.
 
■This technology won the Futuretech Breakthrough Award in 2019 Future Tech Expo. 

■Institutes
National Yang-Ming University
Erh-Hsuan Lin/ehlin@ibms.sinica.edu.tw




本網站使用您的Cookie於優化網站及您的瀏覽經驗。繼續瀏覽網站即表示您同意本公司隱私權政策,您可至隱私權政策了解詳細資訊。